NCT00249132View on ClinicalTrials.gov

A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia

PHASE3CompletedINTERVENTIONAL

Enrollment

523

Participants

Timeline

Start Date

Not specified

Study Completion Date

July 31, 1991

Conditions

SchizophreniaPsychotic Disorders

Interventions

DRUG

risperidone

All Listed Sponsors

lead

Janssen, LP

INDUSTRY